Skip to main content
Midas Edge

NEOGENOMICS INC

For the period ended Mar 31, 2025. Filed Apr 29, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed Apr 29, 2025

NEO$17.60+4.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. Exhibits

Exhibit NumberDescription of ExhibitLocation
3.1Amended and Restated Bylaws, as amendedIncorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2015, as filed with the SEC on November 6, 2015.
3.2Amendment to the Amended and Restated Bylaws of NeoGenomics, Inc.Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on April 8, 2025.
10.1Employment Agreement, executed August 10, 2022, by and between NeoGenomics, Inc. and Alicia OlivoProvided herewith.
10.2Amendment to the Employment Agreement, executed January 1, 2024, by and between NeoGenomics, Inc. and Alicia OlivoProvided herewith.
10.3Employment Agreement effective April 1, 2025, by and between NeoGenomics, Inc. and Anthony Zook.Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on March 31, 2025.
10.4Letter Agreement between NeoGenomics, Inc. and Christopher Smith, dated January 8, 2025.Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on January 10, 2025.
10.5Special Advisor Agreement between NeoGenomics, Inc. and Christopher Smith, effective April 1, 2025.Incorporated by reference to the Company’s Current Report on Form 8-K as filed with the SEC on January 10, 2025.
10.6Separation Agreement, dated as of April 27, 2025, between NeoGenomics Inc. and Melody HarrisProvided herewith.
31.1Certification by Principal Executive Officer pursuant to Rule 13a-14(a)/ 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002Provided herewith.
31.2Certification by Principal Financial Officer pursuant to Rule 13a-14(a)/ 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002Provided herewith.
32.1Certification by Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002Provided herewith.
101.INSXBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)Provided herewith.
101.SCHXBRL Taxonomy Extension Schema DocumentProvided herewith.
101.CALXBRL Taxonomy Extension Calculation Linkbase DocumentProvided herewith.
101.DEFXBRL Taxonomy Extension Definition Linkbase DocumentProvided herewith.
101.LABXBRL Taxonomy Extension Labels Linkbase DocumentProvided herewith.
101.PREXBRL Taxonomy Extension Presentation Linkbase DocumentProvided herewith.
104Cover Page Interactive File (formatted as inline XBRL and contained within Exhibit 101)Provided herewith.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.